 VALENCIA, Calif. and MELBOURNE, Australia, March 01, 2021 GLOBE NEWSWIRE -- AVITA Medical, Inc. Nasdaq: RCEL; ASX: AVH AVITA Medical, a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today announced the successful closing of an underwritten registered public offering of its shares of common stock, the details of which were released to the market on February 24, 2021 United States February 25, 2021 Australia. 